Proteins such as GUSB, ALDH1A1, LPL, IGFBP1/2, CTSD, HMOX1, FGF21, AGRP, and LEP played central roles in modulating MASLD risk. This evidence concerns the gene IGFBP1 and metabolic dysfunction-associated steatotic liver disease.